- Antifungal effects of Metformin against Candida albicans by autophagy regulation
-
Xiao Zhao, Yang Wang, Qinqin Zhang, Yun Huang, Xin Wei, Daming Wu
-
J. Microbiol. 2025;63(4):e2411008. Published online April 29, 2025
-
DOI: https://doi.org/10.71150/jm.2411008
-
-
2,336
View
-
107
Download
-
4
Web of Science
-
6
Crossref
-
 Abstract
 PDF
-
Candida albicans (C. albicans) is a common opportunistic fungal pathogen that can cause infections ranging from superficial to severe systemic diseases. This study investigates the antifungal effects of metformin on C. albicans and explores its underlying mechanisms. Growth inhibition was assessed via XTT assays, and hyphal formation and morphological changes were observed by light microscope and scanning electron microscopy (SEM). Mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) levels were measured with JC-1 and DCFH-DA probes, respectively. Gene expression related to ROS and autophagy was quantified by RT-qPCR, and autophagosomes were visualized using transmission electron microscopy (TEM). Metformin significantly inhibited C. albicans growth and hyphal formation, altered cell morphology, reduced MMP, and increased ROS levels. It activated autophagy in planktonic C. albicans but suppressed it in biofilm forms. Additionally, metformin exhibited synergistic effects with amphotericin B against planktonic C. albicans and with caspofungin against biofilms. The findings suggest that metformin exerts antifungal activity by modulating MMP, ROS levels, and autophagy-related pathways, and enhances the efficacy of specific antifungal drugs.
-
Citations
Citations to this article as recorded by  - Schinus weinmanniifolia as a natural alternative for the control of skin infections: a multifactorial approach against methicillin-resistant Staphylococcus aureus
Cleison Leite, João Andrade, Adriana Almeida-Apolônio, Stéfani Rosa, Thiago Castro, Claudia Cardoso, Fabiana Dantas, Kelly Oliveira
Journal of Ethnopharmacology.2026; 365: 121577. CrossRef - Metformin exerts a dual effect on Mucorales virulence by altering oxidative metabolism through the regulation of rhizoferrin levels
J Alberto Patiño-Medina, Viridiana Alejandre-Castañeda, César J Torres-Cortés, León Francisco Ruíz-Herrera, Marco I Valle-Maldonado, César R Solorio-Alvarado, Joel Ramírez-Emiliano, Karla Viridiana Castro-Cerritos, Rafael Ortíz-Alvarado, Francisco E Nicol
Medical Mycology.2026;[Epub] CrossRef - Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss
Shakta Mani Satyam, Ebrahim Safaii, Ilmia Shameer, Rashmi Kumari, Sainath Prabhakar, Mohamed Talat Zaky Mahmoud Eltrabishi, Mohamed El-Tanani, Abdul Rehman, Mohamed Tarek Mohamed Wageh Mohamed Abdelfattah
Antibiotics.2026; 15(6): 583. CrossRef - Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11
Yanru Feng, Cheng Zhen, Wanqian Li, Malcolm Whiteway, Xinyu Fang, Xuqing Shen, Yuanying Jiang, Hui Lu
Microbiological Research.2026; 311: 128595. CrossRef - Chloroquine Alone and Combined with Antifungal Drug Against Candida albicans Biofilms In Vitro and In Vivo via Autophagy Inhibition
Xiao Zhao, Qiaochu Wu, Chenyu Weng, Shuangbo Xu, Yufei Wang, Weiyu Yuan, Xuening Xiong, Wanjing Chen, Xin Wei
Mycopathologia.2025;[Epub] CrossRef -
Updates on
Candida albicans
infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies
Marilena Pariano, Matteo Puccetti, Consuelo Fabi, Emilia Nunzi, Sarah Balucchi, Luana Perioli, Maurizio Ricci, Stefano Giovagnoli, Enrico Garaci, Luigina Romani
Expert Review of Anti-infective Therapy.2025; 23(10): 951. CrossRef
|
MSK
